| Risk |
Country |
Preferable
regimen |
Alternative regimen |
| Risk high.
Chloroquine resistance high | Bangladesh (only in Chittagong Hill
Tracts; low risk in other areas) India (Assam only) | Mefloquine OR
doxycycline OR Malarone | . |
| Risk variable.
Chloroquine resistance usually moderate
| Bhutan (southern districts
only) India (low risk in some areas - see below, high risk in Assam) Nepal (below
1500m, especially Terai districts; no risk in Kathmandu) Pakistan (below
2000m) Sri Lanka (north of Vavuniya; low risk in other areas) | Chloroquine plus proguanil |
Mefloquine OR doxycycline OR Malarone |
| Risk low. | Bangladesh (but risk high in
Chittagong Hill Tracts) India (Kerala [southern states], Tamil Nadu, Karnataka, Southern Andhra Pradesh [including Hyderabad and Mumbai], Rajasthan [including Jaipur], Uttar Pradesh [including Aggra], Haryana, Uttaranchal, Himachal Pradesh, Jammu, Kashmir, Punjab, Delhi; variable risk in other areas; high risk in Assam) Sri Lanka (but variable risk north of Vavuniya) | Avoid mosquito bites, but remember low risk
exists if fever
develops | . |